Showing results (381-390 of 719) with videos related to
Sort By:
Pageof 72
Leukemia|April 1, 2005
The t(8;17)(p11;q23) in the 8p11 myeloproliferative syndrome fuses MYO18A to FGFR1C Walz, A Chase, C Schoch, et al.Haematologica|July 1, 1997
New insights in biology and current therapeutic options for patients with chronic myelogenous leukemiaA M Carella, F Frassoni, J Melo, et al.The EMBO Journal|October 6, 1997
Fission yeast Cut2 required for anaphase has two destruction boxesH Funabiki, H Yamano, K Nagao, et al.Plos Computational Biology|September 27, 2013
Trial-type dependent frames of reference for value comparisonLaurence T Hunt, Mark W Woolrich, Matthew F S Rushworth, et al.Journal of Computational Chemistry|November 22, 2016
Computing infrared spectra of proteins using the exciton modelFouad S Husseini, David Robinson, Neil T Hunt, et al.Evaluation and Program Planning|April 3, 2019
Examining the impact of a summer learning program on children's weight status and cardiorespiratory fitness: A natural experimentEthan T Hunt, Michelle L Whitfield, Keith Brazendale, et al.Biochemical and Biophysical Research Communications|April 15, 1992
Venous smooth muscle contains vasoconstrictor ETB-like receptorsS Moreland, D M McMullen, C L Delaney, et al.British Journal of Haematology|September 1, 1995
Variable numbers of BCR-ABL transcripts persist in CML patients who achieve complete cytogenetic remission with interferon-alphaA Hochhaus, F Lin, A Reiter, et al.Leukemia|June 24, 2000
Detection and quantification of residual disease in chronic myelogenous leukemiaA Hochhaus, A Weisser, P La Rosée, et al.Leukemia|August 30, 2002
Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon alphaK Merx, M C Müller, S Kreil, et al.Pageof 72